1. Home
  2. OLPX vs SYRE Comparison

OLPX vs SYRE Comparison

Compare OLPX & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OLPX
  • SYRE
  • Stock Information
  • Founded
  • OLPX 2014
  • SYRE 2013
  • Country
  • OLPX United States
  • SYRE United States
  • Employees
  • OLPX N/A
  • SYRE N/A
  • Industry
  • OLPX Package Goods/Cosmetics
  • SYRE Biotechnology: Pharmaceutical Preparations
  • Sector
  • OLPX Consumer Discretionary
  • SYRE Health Care
  • Exchange
  • OLPX Nasdaq
  • SYRE Nasdaq
  • Market Cap
  • OLPX 844.1M
  • SYRE 841.4M
  • IPO Year
  • OLPX 2021
  • SYRE 2016
  • Fundamental
  • Price
  • OLPX $1.32
  • SYRE $15.30
  • Analyst Decision
  • OLPX Hold
  • SYRE Buy
  • Analyst Count
  • OLPX 4
  • SYRE 6
  • Target Price
  • OLPX $1.85
  • SYRE $55.00
  • AVG Volume (30 Days)
  • OLPX 1.3M
  • SYRE 476.1K
  • Earning Date
  • OLPX 05-08-2025
  • SYRE 05-08-2025
  • Dividend Yield
  • OLPX N/A
  • SYRE N/A
  • EPS Growth
  • OLPX N/A
  • SYRE N/A
  • EPS
  • OLPX 0.02
  • SYRE N/A
  • Revenue
  • OLPX $420,742,000.00
  • SYRE N/A
  • Revenue This Year
  • OLPX $1.39
  • SYRE N/A
  • Revenue Next Year
  • OLPX $2.34
  • SYRE N/A
  • P/E Ratio
  • OLPX $71.49
  • SYRE N/A
  • Revenue Growth
  • OLPX N/A
  • SYRE N/A
  • 52 Week Low
  • OLPX $1.01
  • SYRE $10.91
  • 52 Week High
  • OLPX $2.77
  • SYRE $40.26
  • Technical
  • Relative Strength Index (RSI)
  • OLPX 53.79
  • SYRE 51.16
  • Support Level
  • OLPX $1.24
  • SYRE $14.87
  • Resistance Level
  • OLPX $1.30
  • SYRE $15.71
  • Average True Range (ATR)
  • OLPX 0.07
  • SYRE 0.72
  • MACD
  • OLPX 0.00
  • SYRE 0.10
  • Stochastic Oscillator
  • OLPX 45.16
  • SYRE 51.57

About OLPX Olaplex Holdings Inc.

Olaplex Holdings Inc is a science-enabled, technology-driven beauty company. It offers science-backed solutions that improve hair health. It identifies the majority of consumers' relevant haircare concerns in collaboration with the community of professional hairstylists and consumers and strives to address them through its proprietary technology and innovation capabilities. It offers products through an omnichannel platform that serves professional, specialty retail, and DTC channels. The company derives its revenue through the sale of its hair care products. The company generates the majority of revenue from Professional sales channels followed by Specialty Retail and then DTC. Geographically the company generates the majority of its revenue from the International market.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: